Search for: "Boehringer Ingelheim GmbH"
Results 41 - 51
of 51
Sorted by Relevance
|
Sort by Date
6 Feb 2009, 5:00 am
Stem cell research under Obama (Ars Technica) US: Oxford Gene Technology settles legal action with Bioarray Solutions over patents covering use of microassays for detection of DNA sequence variations (Patent Docs) US: BPAI affirms rejection of claims to an isolated protein over prior art disclosing nucleic acid encoding the protein: Ex parte Chuang (not precedential) (Patent Docs) (Post-Grant) US: Supreme petitioned to grant certiorari in two cases important to biotech patenting: In re Bilski and… [read post]
31 Dec 2008, 2:35 pm
Article 7(2) of Directive 89/104 ... is to be interpreted as meaning that it is for the parallel importer to furnish to the proprietor of the trade mark the information which is necessary and sufficient to enable the latter to determine whether the repackaging of the product under that trade mark is necessary in order to market it in the Member State of importation".The IPKat knows how pleased the Court of Appeal for England and Wales will be now that this ruling has been given, since that… [read post]
27 May 2010, 3:20 am
Boehringer Ingelheim International GMBH et al. [read post]
15 Nov 2016, 2:00 pm
Boehringer Ingelheim GMBH, 237F.3d 1359, 1365 (Fed. [read post]
1 May 2010, 11:00 am
The present decision deals with the refusal of an application on the ground of unallowable double patenting. [read post]
4 May 2017, 1:00 am
Relevant Judicial Practice Boehringer Ingelheim Pharma GmbH & Co KG v. [read post]
22 Feb 2008, 6:00 pm
: (GenericsWeb), EU: Pharmaceutical sector enquiry regarding possible misuse of IP rights: (GenericsWeb), India: Indian government seeks to be a leader in deep sea bed mining to provide competitive edge for pharmaceutical companies in the development of new drugs: (Spicy IP),India : Medical Devices Regulation Bill formulated: (Spicy IP),India : Pharma gets bigger - Novo Nordisk and Merck & Co expansion plans: (Spicy IP),India : US patent reform and the Indian generics market: (Patent… [read post]
16 Aug 2008, 2:43 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
11 Jul 2008, 4:30 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
2 Nov 2010, 1:40 am
AstraZeneca sought and got a preliminary injunction against Apotex, which was hankering to launch a generic version of the asthma drug Pulmicort. [read post]
